Brief: Double Bond Pharmaceutical Has Been Granted Eurostars Funding
16/07/2018 07:07
July 16 (Reuters) - DOUBLE BOND PHARMACEUTICAL INTERNATIONAL
AB (PUBL) DBPHAb.TE :
* DOUBLE BOND PHARMACEUTICAL HAS BEEN GRANTED EUROSTARS
FUNDING
FOR DEVELOPMENT A NEW PRODUCT FOR TREATMENT OF PNEUMONIA
* TOTAL INVESTMENT OF THIS PROJECT IS ABOUT EUR 1.33M
* PROJECT WILL BE CONDUCTED FOR 2 YEARS WITH START IN
NOVEMBER
2018
Source text for Eikon: ID:nWkr6wDJrh
Further company coverage: DBPHAb.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 587720920;))
Recent news on Double Bond Pharmaceutical International AB (publ)
See all newsBrief: DBP International AB And Vivo Biopharma LLC Revised Asset Purchase And Collaboration Agreements
Brief: DBP International AB And Vivo Biopharma LLC Enter Into Asset Purchase And Collaboration Agreements To Develop And Commercialize A Novel Glioblastoma Treatment
Brief: DBP And Vivo Enter Into Asset Purchase And Collaboration Agreements To Develop And Commercialize A Novel Glioblastoma Treatment
Brief: Double Bond Pharmaceutical Says Positive Response For SI-053 From Ethical Committee In Netherlands Has Been Received
Brief: Double Bond To Cooperate With Belarus State Medical University